InvestorsHub Logo
Followers 36
Posts 2689
Boards Moderated 0
Alias Born 06/09/2011

Re: ATLnsider post# 417721

Tuesday, 11/16/2021 9:03:36 AM

Tuesday, November 16, 2021 9:03:36 AM

Post# of 688742
I saw that as well ATLnsider and caught my attention. Agree with you 100%!

Message in reply to:

These statements are very encouraging, forward-looking, and tells us some of the things NWBio has been spending money on recently:

Quote:
Our operating costs also include the costs of preparations for new or expanded clinical trial programs, such as our planned Phase II clinical trials. The preparation costs include payments to regulatory consultants, lawyers, statisticians, sites and others, evaluation of potential investigators, the clinical trial sites and the CROs managing the trials and other service providers, and expenses related to institutional approvals, clinical trial agreements (business contracts with sites), training of medical and other site personnel, trial supplies and other. Additional substantial costs relate to the maintenance and substantial expansion of manufacturing capacity, in both the U.S. and Europe.


Also, please note that the words clinical trials are plural, in this sentence:

Quote:
such as our planned Phase II clinical trials


And, alsn note that NWBio is expanding manufacturing capacity in the "U.S. and Europe"

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News